InvestorsHub Logo
icon url

theswordman

05/21/23 3:21 PM

#17416 RE: Sukyamadda #17415

There is no doubt the media is gone
Covid hopefully fading but long covid--that will be here for a long while sadly
People are still dieing from covid and still get infected. Will try and post the BNO #s 2nite. The mortality is holding between 1000 and 1500 / week. Maybe this is the week it drops--we can hope

With Putrino Labs showing 100% correlation in EVERY long covid case and microclots--this is not good
Maybe soon they get a test for microclots then a treatment--for now --not there

The Dr in Birmingham is testing for microclots with biomarkers and treats. Hasn't stated his Rx protocol IIRC--but the std anti coags are not it

AS far as Tollovid sales--they are out of stock@ Amazon so there are sales
Someday we will get the #s and each person can spin away.
icon url

vcf5502

05/21/23 4:20 PM

#17417 RE: Sukyamadda #17415

Suky,
You ask "After the only testing contract fails where is the revenue?"

The website says Todos Botanicals will have 50 MILLION REVENUE in 2023.
So I assume the money is gummies, creams and tinctures lol.

How are they gonna sell 50 million? Has even 1 machine been installed yet?


All in my opinion.
icon url

GreeseMonkey

05/21/23 8:01 PM

#17422 RE: Sukyamadda #17415

The media might be moving on from Covid and Long Covid, but I do think Gerald is right in his predictions on Twitter, that at some point not too far away, attention will swing back to Covid as it begins to impact work force and medical costs as a nation. The data Todos has gathered should be of value when that happens. I also believe whoever the investor is that will fund 3CL Pharma understand this. Making investment decisions in a company like Todos isn't always about what the media is reporting. The media is usually wrong, especially in areas of investments or stock market forecasting. My opinion only.